SureTrader
Home > Boards > US OTC > Biotechs > CYTODYN INC (CYDY)

I agree. I listened to the call on

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Inoviorulez Member Profile
 
Followed By 26
Posts 1,409
Boards Moderated 1
Alias Born 09/25/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 4/11/2018 6:09:06 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/9/2018 4:34:49 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 3/26/2018 5:27:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/26/2018 5:25:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/26/2018 8:02:44 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 3/26/2018 6:02:12 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/23/2018 4:28:34 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 3/23/2018 4:22:05 PM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 3/22/2018 7:33:32 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 3/20/2018 7:37:02 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/20/2018 7:32:32 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/20/2018 6:09:16 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/20/2018 6:09:16 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 3/14/2018 3:03:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/14/2018 7:32:05 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 3/9/2018 5:07:49 PM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) Edgar (US Regulatory) - 3/9/2018 4:43:58 PM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) Edgar (US Regulatory) - 3/9/2018 4:01:33 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 3/8/2018 6:03:09 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/28/2018 5:47:33 PM
Amended Small Company Offering and Sale of Securities Without Registration (d/a) Edgar (US Regulatory) - 2/28/2018 2:06:16 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 2/23/2018 5:23:20 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/20/2018 4:42:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2018 4:39:35 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/20/2018 6:33:17 AM
Inoviorulez   Thursday, 11/09/17 10:19:09 PM
Re: gestalt2 post# 17982
Post # of 21878 
I agree. I listened to the call on October 19, 2017. Basically the FDA stated that for the efficacy to be relevant the company has to enroll 50. This was stated after the FDA saw the data for the 30 patients. The FDA decided that the data wouldn't be relevant with only the 30 patients so they upped the target to 50. You can't control how the FDA will react when it gets a response from a company. I understand people are frustrated because of the delay, but such a delay was not CYDY's fault. It was the FDA that changed their minds, and the FDA has every right to do whatever it wants.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist